FDA Advisory Panel Rejects Novel ALS Drug
A US Food and Drug Administration advisory committee is unconvinced by that a new drug for amyotrophic lateral sclerosis is effective.
Source: medscape.com
📰 Accurate Rest News
Accurate Rest News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Accurate Rest. Real-time updates on events, politics, business and more.